levonorgestrel has been researched along with Adenomyosis in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 26 (45.61) | 24.3611 |
2020's | 31 (54.39) | 2.80 |
Authors | Studies |
---|---|
Fu, X; Gong, H; Lan, R; Wang, S; Yang, H | 1 |
Cheng, L; Nie, LK; Zhang, PH; Zou, HL | 1 |
Marquez, CM; Sadowski, EA; Schrager, S; Yogendran, L | 1 |
A, P; Abraham, JJ; George, M; Rathinam, KK; S A, S; S, HP; Sen, M | 1 |
Baracat, EC; Ferreira-Filho, ES; Magalhaes, J; Soares-Junior, JM | 1 |
Fan, LX; Li, RN; Pang, LL; Wen, Y; Yang, LL; Zhao, TT | 1 |
Akira, S; Harada, T; Hirano, K; Kitawaki, J; Maeda, N; Momoeda, M; Ota, I; Sunaya, T; Umeyama, M | 1 |
Akaeda, S; Fukui, Y; Hiraoka, T; Hirata, T; Hirota, Y; Iida, R; Ishizawa, C; Kaku, T; Matsuo, M; Omura, E; Osuga, Y | 1 |
Ma, X; Wang, S; Wang, W; Wu, Z; Xiang, T; Zhang, M | 1 |
Cao, B; Chen, L; Guo, J; Niu, Z; Tong, J; Zhang, H; Zheng, J; Zhu, L | 1 |
Di, X; Leilei, G; Na, L; Rong, S | 1 |
Dong, G; Li, Y; Ma, Q; Mu, Y; Song, S; Yang, L; Zhu, H | 1 |
Dai, Y; Leng, JH; Li, XY; Shi, JH; Zhu, SY | 1 |
Chuang, LT; Jeng, CJ; Otgontuya, A; Shen, J; Wu, TN | 1 |
Abraham, JJ; George, M; Karuppaiah, H; Rathinam, KK; Samal, S; Selvaraj, HP | 1 |
Cai, Y; Cao, Q; Gao, B; Hao, X; Ren, C; Sun, Y; Wu, Y; Xu, F | 1 |
Chen, Y; Dong, H; Huang, L; Huang, X; Li, J; Li, X; Shunshi, Y; Yu, F; Zhang, Q; Zhao, X | 1 |
Guo, W; Hu, S; Lin, Y; Shen, Y | 1 |
Barra, F; Bogliolo, S; Ceccaroni, M; Chiantera, V; Etrusco, A; Evangelisti, G; Ferrero, S; Izzotti, A; Laganà, AS; Oral, E; Pastore, M; Venezia, R | 1 |
Haiyan, S; Lin, W; Shuhua, H; Wang, W | 1 |
Abbas, AM; Abdallah, A; Abdelkader, AM; Abdellah, AM; Abdelrahman, RM; Aboelroose, AA; Atwa, K; Badran, E; El Bahie, AM; El Gedawy, AM; Elsenity, MA; Ghoneim, HM; Lotfy, M; Mostafa, M; Saber Mohammed, H; Safwat, S; Salah El Din, AS; Samy, A; Samy, M | 1 |
Kim, DE; Kim, HY; Lee, KH; Lee, S; Lee, SY; Park, DB; Song, SY; Yang, JB; Yoo, HJ | 1 |
Chen, C; Li, N; Li, Q; Wang, G; Yuan, M; Zhen, Q | 1 |
Liang, N; Ma, L; Shi, W; Wang, H; Wang, L; Zhang, W | 1 |
Ainsworth, AJ; Cope, AG; Stewart, EA | 1 |
Sun, F; Xu, H; Yang, Y; You, M; Yu, Y; Zhang, Y | 1 |
Chao, X; Lang, J; Li, L; Song, X; Wu, H; You, Y | 1 |
Guo, R; Hai, N; Hou, Q | 1 |
Bellati, F; Caserta, D; Ciancia, M; Colombrino, C; Costanzi, F; Cozza, G; De Marco, MP; Frega, A; Ruscito, I; Torcia, F | 1 |
Cao, B; Tang, S; Tong, J; Yang, X; Zhu, L | 1 |
Abdul Rahman, N; Ahmad, ZA; Mohd Zahid, AZ | 1 |
Dai, Y; Jin, P; Peng, Y; Wen, C; Yang, X; Yu, G | 1 |
Chen, L; Hu, J; Huang, Y; Wu, J; Zou, Y | 1 |
Gao, Y; Jiang, J; Li, D; Shan, S; Shi, B; Zhao, X | 1 |
Aili, A; Feng, X; Lin, B; Yang, X; Zhang, X | 1 |
Kuang, Y; Liang, Z; Ma, M; Wang, Y; Yin, M | 1 |
Jia, S; Lang, J; Leng, J; Li, L | 1 |
Chen, Z; Yang, H; Zhang, L; Zhang, X | 1 |
Chen, Z; Huang, X; Lou, J; Xu, P; Zhang, L; Zhang, X | 1 |
Kong, B; Li, L; Song, K; Yukuwa, K; Zhang, P | 1 |
Ayağ, ME; Cengiz, H; Ekin, M; Kaya, C; Savan, K; Yasar, L | 1 |
Celimli, FH; Mun, S; Taner, CE; Uysal, A; Uysal, F | 1 |
Munro, MG; Solnik, MJ | 1 |
Chen, X; Wu, X; Zhu, H | 1 |
Bastianelli, C; Benagiano, G; Brosens, I; Farris, M | 1 |
Ai Xing Zi, AL; Ding, Y; Ha Ni Ke Zi, TX; He, Y; Ji, F; Yang, XH | 1 |
Cheng, C; Gui, T; Huang, MH; Ma, XP; Wan, GP; Xun, AH; Zhu, L | 1 |
Cho, S; Choi, YS; Chon, SJ; Jung, YS; Kim, H; Kim, SH; Lee, BS; Park, JH; Seo, SK; Yun, BH | 1 |
Cho, S; Choi, YS; Jeon, YE; Lee, BS; Park, JH; Seo, SK; Yoon, SO; Yun, BH | 1 |
Abd El Aal, DE; Ali, MK; Sabra, AM; Shaaban, OM | 1 |
Jun, HS; Kim, MK; Kim, ML; Park, DS; Seong, SJ; Song, T; Yun, BS | 1 |
Kang, BH; Kim, JK; Ko, YB; Lee, KH; Lee, MA; Yang, JB; Yoo, HJ | 1 |
Chang, XY; Dai, Y; Jia, SZ; Lang, JH; Leng, JH; Li, L; Li, T; Li, XY; Liu, ZZ; Shi, JH; Xu, XX; You, SS; Zhang, JJ; Zhang, JR | 2 |
Chang, XY; Jia, SZ; Lang, YH; Leng, JH; Li, L; Li, XY; Liu, ZZ; Shi, JH; You, SS; Zhang, JJ | 1 |
Dukhin, AO; Khamoshina, MB; Lebedeva, MG; Nosenko, EN; Orazmuradov, AA; Orazov, MR; Radzinsky, VE; Sojunov, MA | 1 |
Kelekci, KH; Kelekci, S; Yilmaz, B | 1 |
9 review(s) available for levonorgestrel and Adenomyosis
Article | Year |
---|---|
Evaluation of pharmacological interventions in the management of adenomyosis: a systematic review.
Topics: Adenomyosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel | 2022 |
Efficacy of high-intensity focused ultrasound combined with LNG-IUS for adenomyosis: a systematic review and meta-analysis.
Topics: Adenomyosis; Dysmenorrhea; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Uterus | 2023 |
Comparison of the treatment efficacies of HIFU, HIFU combined with GnRH-a, and HIFU combined with GnRH-a and LNG-IUS for adenomyosis: A systematic review and meta-analysis.
Topics: Adenomyosis; Dysmenorrhea; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Treatment Outcome | 2023 |
Evaluation of Endpoints Used in Clinical Trials on Adenomyosis - A Systematic Review.
Topics: Adenomyosis; Female; Humans; Levonorgestrel; Uterus | 2023 |
Current Medical Therapy for Adenomyosis: From Bench to Bedside.
Topics: Adenomyosis; Female; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Progestins; Quality of Life; Uterus | 2023 |
The role of levonorgestrel intra-uterine system in the management of adenomyosis: A systematic review and meta-analysis of prospective studies.
Topics: Adenomyosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Progesterone Congeners; Prospective Studies; Treatment Outcome; Uterus | 2020 |
Current and Future Medical Therapies for Adenomyosis.
Topics: Adenomyosis; Dysmenorrhea; Female; Hormone Antagonists; Humans; Levonorgestrel; Menorrhagia; Nandrolone; Pain Measurement; Quality of Life | 2020 |
Indications and alternatives to hysterectomy.
Topics: Adenomyosis; Aromatase Inhibitors; Chronic Pain; Endometrial Hyperplasia; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Hysteroscopy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Pelvic Pain; Polyps; Uterine Artery Embolization; Uterine Diseases; Uterine Hemorrhage; Uterine Myomectomy; Uterine Neoplasms | 2014 |
Selective progesterone receptor modulators: an update.
Topics: Adenomyosis; Animals; Clinical Trials as Topic; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Postcoital; Endometriosis; Estrenes; Female; Hormone Antagonists; Humans; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Receptors, Progesterone; Uterine Neoplasms | 2014 |
5 trial(s) available for levonorgestrel and Adenomyosis
Article | Year |
---|---|
Compare the Efficacy of Dienogest and the Levonorgestrel Intrauterine System in Women with Adenomyosis.
Topics: Adenomyosis; Female; Humans; Levonorgestrel; Nandrolone; Pain | 2023 |
Efficacy of combined levonorgestrel-releasing intrauterine system with gonadotropin-releasing hormone analog for the treatment of adenomyosis.
Topics: Adenomyosis; Drug Delivery Systems; Dysmenorrhea; Female; Goserelin; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Organ Size; Pain; Progestins; Uterus | 2013 |
Effects of the levonorgestrel-releasing intrauterine system on urinary symptoms in patients with adenomyosis.
Topics: Adenomyosis; Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Levonorgestrel; Middle Aged; Pilot Projects; Quality of Life; Ultrasonography; Urinary Incontinence | 2013 |
[Treatment of adenomyosis patients by bushen huoxue sanyu decoction: a clinical study].
Topics: Adenomyosis; Drugs, Chinese Herbal; Dysmenorrhea; Female; Humans; Levonorgestrel | 2014 |
Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial.
Topics: Adenomyosis; Adult; Contraceptives, Oral, Combined; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Uterus | 2015 |
43 other study(ies) available for levonorgestrel and Adenomyosis
Article | Year |
---|---|
Effect of modified levonorgestrel-releasing intrauterine system in human adenomyosis with heavy menstrual bleeding.
Topics: Adenomyosis; Dysmenorrhea; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia | 2022 |
Subcutaneous etonogestrel implant combined with endometrial ablation for the treatment of adenomyosis: two case reports.
Topics: Adenomyosis; Desogestrel; Endometrial Ablation Techniques; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel | 2022 |
Adenomyosis: Diagnosis and Management.
Topics: Adenomyosis; Adult; Contraceptive Agents, Hormonal; Endometriosis; Female; Humans; Hysterectomy; Infertility; Intrauterine Devices, Medicated; Levonorgestrel; Magnetic Resonance Imaging; Menorrhagia; Middle Aged; Pelvic Pain; Pregnancy; Risk Factors; Ultrasonography | 2022 |
Uterine volume, menstrual patterns, and contraceptive outcomes in users of the levonorgestrel-releasing intrauterine system: A cohort study with a five-year follow-up.
Topics: Adenomyosis; Cohort Studies; Contraceptive Agents; Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Uterine Hemorrhage | 2022 |
Real-world outcomes of the levonorgestrel-releasing intrauterine system for heavy menstrual bleeding or dysmenorrhea in Japanese patients: A prospective observational study (J-MIRAI).
Topics: Adenomyosis; Chronic Pain; Dysmenorrhea; Female; Follow-Up Studies; Humans; Japan; Levonorgestrel; Menorrhagia; Pelvic Pain; Prospective Studies | 2022 |
Levonorgestrel-Releasing Intrauterine System Improves Menorrhagia-Related Quality of Life in Patients with Symptomatic Adenomyosis.
Topics: Adenomyosis; Dysmenorrhea; Female; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Quality of Life | 2023 |
Comparison of recurrence rate and risk factors in patients with focal adenomyosis with and without medical treatment after conservative surgery.
Topics: Adenomyosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Recurrence; Retrospective Studies; Risk Factors | 2023 |
An innovative surgical approach: suture fixation of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis.
Topics: Adenomyosis; Dysmenorrhea; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Quality of Life; Sutures | 2022 |
Effect of Implantation and Fixation of Mirena in the Treatment of Adenomyosis and its Influence on Serum Inflammatory Factors.
Topics: Adenomyosis; Dysmenorrhea; Female; Humans; Levonorgestrel; Quality of Life; Uterus | 2022 |
Clinical evaluation of high-intensity focused ultrasound ablation combined with mifepristone and levonorgestrel-releasing intrauterine system to treat symptomatic adenomyosis.
Topics: Adenomyosis; Child; Dysmenorrhea; Female; High-Intensity Focused Ultrasound Ablation; Humans; Levonorgestrel; Mifepristone | 2023 |
The role of levonorgestrel-releasing intrauterine system for recurrence prevention after conservative surgery among patients with coexistent ovarian endometrioma and diffuse adenomyosis: A retrospective case control study with long-term follow up.
Topics: Adenomyosis; Case-Control Studies; Dysmenorrhea; Endometriosis; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Retrospective Studies | 2023 |
Effects of high-intensity focused ultrasound combined with levonorgestrel-releasing intrauterine system on patients with adenomyosis.
Topics: Adenomyosis; Dysmenorrhea; Female; Humans; Levonorgestrel; Retrospective Studies; Uterus | 2023 |
Transvaginal ultrasound- and laparoscopy-guided percutaneous microwave ablation for adenomyosis has short- and long-term benefits: a single-center study.
Topics: Adenomyosis; Adult; Dysmenorrhea; Female; Humans; Laparoscopy; Levonorgestrel; Microwaves | 2023 |
High-intensity focused ultrasound (HIFU) combined with gonadotropin-releasing hormone analogs (GnRHa) and levonorgestrel-releasing intrauterine system (LNG-IUS) for adenomyosis: a case series with long-term follow up.
Topics: Adenomyosis; Adult; Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; High-Intensity Focused Ultrasound Ablation; Humans; Levonorgestrel; Middle Aged | 2019 |
Long-term efficacy and feasibility of levonorgestrel-releasing intrauterine device use in patients with adenomyosis.
Topics: Adenomyosis; Adult; Contraceptive Agents, Hormonal; Feasibility Studies; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Organ Size; Pain Management; Retrospective Studies; Time Factors; Uterus | 2020 |
The efficacy of medical treatment for adenomyosis after adenomyomectomy.
Topics: Adenomyosis; Dysmenorrhea; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Treatment Outcome | 2020 |
Levonorgestrel Ameliorates Adenomyosis via lncRNA H19/miR-17/TLR4 Pathway.
Topics: Adenomyosis; Adult; Apoptosis; Cell Proliferation; Humans; Levonorgestrel; MicroRNAs; RNA, Long Noncoding; Toll-Like Receptor 4 | 2020 |
Laparoscopic adenomyomectomy combined with levonorgestrel-releasing intrauterine system in the treatment of adenomyosis: Feasibility and effectiveness.
Topics: Adenomyosis; Feasibility Studies; Female; Humans; Intrauterine Devices, Medicated; Laparoscopy; Levonorgestrel; Menorrhagia | 2021 |
Adjuvant therapy in conservative surgery for adenomyosis.
Topics: Adenomyosis; Adult; Combined Modality Therapy; Delayed-Action Preparations; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged | 2021 |
Ultrasound-guided transvaginal radiofrequency ablation combined with levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyosis treatment.
Topics: Adenomyosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Radiofrequency Ablation; Ultrasonography, Interventional | 2021 |
The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports.
Topics: Adenomyosis; Adult; Cohort Studies; Dysmenorrhea; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Prospective Studies; Ultrasonography | 2021 |
The suture fixation of levonorgestrel-releasing intrauterine device using the hysteroscopic cold-knife surgery system: an original method in treatment of adenomyosis.
Topics: Adenomyosis; Adult; Contraceptive Agents, Hormonal; Cryosurgery; Female; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Suture Techniques; Treatment Outcome | 2021 |
Combination of hysteroscopic resection of endomyometrium with insertion of Mirena: An alternative treatment for adenomyosis.
Topics: Adenomyosis; Female; Humans; Hysterectomy; Levonorgestrel | 2021 |
Clinical evaluation of HIFU combined with GnRH-a and LNG-IUS for adenomyosis patients who failed to respond to drug therapies: two-year follow-up results.
Topics: Adenomyosis; Dysmenorrhea; Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel | 2021 |
Treatment of Adenomyosis with Subcutaneous Etonogestrel Implants: A Clinical Observational Study in 17 Patients.
Topics: Adenomyosis; Adult; China; Desogestrel; Dysmenorrhea; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Injections, Subcutaneous; Levonorgestrel; Luteinizing Hormone; Middle Aged; Uterus | 2018 |
Clinical efficacy of adenomyomectomy using "H" type incision combined with Mirena in the treatment of adenomyosis.
Topics: Adenomyosis; Adult; CA-125 Antigen; Contraceptive Agents, Female; Dysmenorrhea; Female; Gynecologic Surgical Procedures; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Organ Size; Pain Measurement; Postoperative Period; Pregnancy; Uterus | 2019 |
Combined therapeutic effects of HIFU, GnRH-a and LNG-IUS for the treatment of severe adenomyosis.
Topics: Adenomyosis; Extracorporeal Shockwave Therapy; Female; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel | 2019 |
Effect of pretreatment with a levonorgestrel-releasing intrauterine system on IVF and vitrified-warmed embryo transfer outcomes in women with adenomyosis.
Topics: Adenomyosis; Adult; Case-Control Studies; China; Cohort Studies; Embryo Transfer; Embryo, Mammalian; Female; Fertilization in Vitro; Humans; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Preconception Care; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Retrospective Studies; Time Factors; Treatment Outcome; Vitrification | 2019 |
Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system.
Topics: Adenomyosis; Adult; CA-125 Antigen; China; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Menstruation; Middle Aged; Prospective Studies; Treatment Outcome; Ultrasonography; Visual Analog Scale | 2019 |
[Efficacy and adverse effects of levonorgestrel-releasing intrauterine system in treatment of adenomyosis].
Topics: Adenomyosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Retrospective Studies | 2019 |
[The second generation endometrial ablation (NovaSure) improves efficacy of levonorgestrel-releasing intrauterine system in management of adenomyosis].
Topics: Adenomyosis; Dysmenorrhea; Endometrial Ablation Techniques; Female; Humans; Levonorgestrel; Organ Size; Retrospective Studies; Uterus | 2019 |
Use of a levonorgestrel-releasing intrauterine device in the treatment of adenomyosis associated heavy menstrual bleeding.
Topics: Adenomyosis; Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Retrospective Studies; Treatment Outcome | 2013 |
Acute urticaria as a side effect of the Mirena® (levonorgestrel-releasing intrauterine system): a case report.
Topics: Acute Disease; Adenomyosis; Adult; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Menorrhagia; Urticaria | 2014 |
Role of levonorgestrel-releasing intrauterine system in dysmenorrhea due to adenomyosis and the influence on ovarian function.
Topics: Adenomyosis; Adult; Dysmenorrhea; Female; Follicle Stimulating Hormone; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Luteinizing Hormone; Middle Aged; Pain Measurement | 2014 |
Effects of levonorgestrel-releasing intrauterine system on lymphangiogenesis of adenomyosis.
Topics: Adenomyosis; Adult; Female; Humans; Hysterectomy; Immunohistochemistry; Intrauterine Devices, Medicated; Levonorgestrel; Lymphangiogenesis | 2015 |
Effects of a Levonorgestrel-Releasing Intrauterine System on the Expression of Steroid Receptor Coregulators in Adenomyosis.
Topics: Adenomyosis; Adult; Cell Proliferation; Endometrium; Female; Humans; Immunohistochemistry; Intrauterine Devices; Levonorgestrel; Nuclear Receptor Coactivator 2; Nuclear Receptor Coactivator 3; Retrospective Studies; Signal Transduction | 2015 |
Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis.
Topics: Adenomyosis; Adult; Cohort Studies; Device Removal; Dysmenorrhea; Female; Follow-Up Studies; Gestational Age; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Pregnancy; Retrospective Studies; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome; Ultrasonography | 2015 |
Relationship between uterine volume and discontinuation of treatment with levonorgestrel-releasing intrauterine devices in patients with adenomyosis.
Topics: Adenomyosis; Adult; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Retrospective Studies; Treatment Failure; Uterus | 2016 |
[A prospective cohort study on effects of levonorgestrel-releasing intrauterine system for adenomyosis with severe dysmenorrhea].
Topics: Adenomyosis; Adult; Contraceptive Agents, Female; Dysmenorrhea; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Pain Measurement; Prospective Studies; Severity of Illness Index; Treatment Outcome; Ultrasonography | 2016 |
[A prospective study on the effects of levonorgestrel-releasing intrauterine system for adenomyosis with menorrhagia].
Topics: Adenomyosis; Adult; Contraceptive Agents, Female; Dysmenorrhea; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Prospective Studies; Severity of Illness Index; Treatment Outcome; Ultrasonography | 2016 |
[A prospective cohort study on the impact of placement timing of LNG-IUS for adenomyosis].
Topics: Adenomyosis; Adult; Dysmenorrhea; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Prospective Studies; Young Adult | 2016 |
Treatment strategies for pelvic pain associated with adenomyosis.
Topics: Adenomyosis; Adult; Chronic Pain; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Outcome Assessment, Health Care; Pelvic Pain | 2016 |
Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
Topics: Adenomyosis; Adult; Contraceptive Agents, Female; Dysmenorrhea; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged | 2012 |